v3.26.1
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 37,617 $ 61,289
General and administrative 8,494 5,483
Total operating expenses 46,111 66,772
Operating loss (46,111) (66,772)
Interest and investment income 2,791 2,385
Net loss (43,320) (64,387)
Unrealized gain (loss) on marketable securities (284) 194
Total other comprehensive gain (loss) (284) 194
Total comprehensive loss $ (43,604) $ (64,193)
Share information:    
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.96) $ (1.9)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.96) $ (1.9)
Weighted-average shares of common stock outstanding, basic (in shares) 45,067,658 33,898,870
Weighted-average shares of common stock outstanding, diluted (in shares) 45,067,658 33,898,870